The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 11 October 2005, www.theannals.com, DOI 10.1345/aph.1G356.
 The Annals of Pharmacotherapy: Vol. 39, No. 11, pp. 1828-1832. DOI 10.1345/aph.1G356
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiel, P. J
Right arrow Articles by McCord, A. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiel, P. J
Right arrow Articles by McCord, A. D

DIABETES

Pharmacist Impact on Clinical Outcomes in a Diabetes Disease Management Program via Collaborative Practice

Patrick J Kiel, PharmD

Department of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, IL

Amie D McCord, PharmD BCPS CDE

Assistant Professor, Department of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University

Reprints: Dr. McCord, Department of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, 555 31st St., Downers Grove, IL 60515-1235, fax 630/515-6958, Amccor{at}midwestern.edu

BACKGROUND: Clinical outcomes resulting from pharmaceutical care have been incompletely addressed in the diabetes population. We conducted a retrospective study evaluating clinical outcomes in a diabetes disease management program in which clinical pharmacists possessed collaborative practice agreements.

OBJECTIVE: To evaluate changes in clinical outcomes for patients enrolled in a pharmacist-coordinated diabetes management program.

METHODS: Medical records of 157 patients enrolled in the diabetes management program between June 2003 and April 2004 were retrospectively reviewed. Data collection included baseline and follow-up values for hemoglobin A1C (A1C) and lipids as well as frequency of adherence to preventive care, including annual foot and eye examinations and daily aspirin therapy.

RESULTS: For patients with both baseline and follow-up data, the mean A1C reduction was 1.6% (n = 109; p < 0.001). For patients with an initial A1C of ≥8.5%, the mean reduction was 2.7% (n = 57; p < 0.001). The percentage of patients with A1C ≤7% increased from 19% at baseline to 50% at follow-up (p < 0.001). The mean low-density lipoprotein (LDL) reduction observed was 16 mg/dL (n = 73; NS) and the percentage of patients with LDL values ≤100 mg/dL increased from 30% at baseline to 56% at follow-up (p < 0.001). The frequency of microalbumin screening increased by 27% (p < 0.001), and the number of patients with annual eye and foot examinations increased by 27% (p < 0.05) and 15% (p < 0.05), respectively. The percentage of patients who had a positive microalbumin test and were taking a renal protective agent rose 19% from baseline to follow-up (NS). The percentage of patients taking daily aspirin increased from 42% at baseline to 80% at follow-up (p < 0.01).

CONCLUSIONS: The pharmacist-coordinated diabetes management program was effective in improving clinical markers for enrolled patients. Significant improvements were observed in A1C and LDL values as well as the frequency of adherence to preventive care.

Key Words: diabetes mellitus, disease management, interdisciplinary care

Published Online, October 11, 2005. www.theannals.com, DOI 10.1345/aph.1G356


This article has been cited by other articles:


Home page
 Journal of Pharmacy PracticeHome page
S. L. Pinto
Determining Change in Self-Perceived Knowledge and Skills About Disease/ Medication Therapy Management Programs in P3 Students
Journal of Pharmacy Practice, June 1, 2009; 22(3): 312 - 319.
[Abstract] [PDF]

Home page
 The Annals of PharmacotherapyHome page
B. Maack, D. R Miller, T. Johnson, and M. Dewey
Economic Impact of a Pharmacy Resident in an Assisted Living Facility-Based Medication Therapy Management Program
Ann. Pharmacother., November 1, 2008; 42(11): 1613 - 1620.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
K. L. Ramser, L. R. Sprabery, C. M. George, G. L. Hamann, V. A. Vallejo, C. S. Dorko, and D. A. Kuhl
Physician-Pharmacist Collaboration in the Management of Patients With Diabetes Resistant to Usual Care
Diabetes Spectr, July 1, 2008; 21(3): 209 - 214.
[Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
N. T. Nkansah, J. M. Brewer, R. Connors, and K. M. Shermock
Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice
Am. J. Health Syst. Pharm., January 15, 2008; 65(2): 145 - 149.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. Machado, J. Bajcar, G. C Guzzo, and T. R Einarson
Sensitivity of Patient Outcomes to Pharmacist Interventions. Part I: Systematic Review and Meta-Analysis in Diabetes Management
Ann. Pharmacother., October 1, 2007; 41(10): 1569 - 1582.
[Abstract] [Full Text] [PDF]

Home page
 J Am Board Fam MedHome page
G. Rust and L. A. Cooper
How Can Practice-based Research Contribute to the Elimination of Health Disparities?
J Am Board Fam Med, March 1, 2007; 20(2): 105 - 114.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.